ReproCELLorp (FRA:6RC) Cyclically Adjusted Revenue per Share: €0.11 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6RC ReproCELL Incorp FRA:6RC
57 GF Score
Price €0.47
GF Value €0.59
! 3 Warning Signs
View Full Analysis

What is ReproCELLorp Cyclically Adjusted Revenue per Share?

ReproCELLorp FRA:6RC -0.42% 57 Cyclically Adjusted Revenue per Share is €0.11 as of Mar. 2026. GuruFocus rates FRA:6RC with a GF Score™ of 57/100 and a GF Value™ of €0.59. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ReproCELLorp's adjusted revenue per share for the three months ended in Mar. 2026 was €0.036. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, ReproCELLorp's average Cyclically Adjusted Revenue Growth Rate was 2.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of ReproCELLorp was 8.50% per year. The lowest was 8.50% per year. And the median was 8.50% per year.

As of today (2026-07-19), ReproCELLorp's current stock price is €0.474. ReproCELLorp's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €0.11. ReproCELLorp's Cyclically Adjusted PS Ratio of today is 4.31.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ReproCELLorp was 17.64. The lowest was 4.08. And the median was 7.21.


ReproCELLorp  (FRA:6RC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ReproCELLorp's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.474/0.11
=4.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ReproCELLorp was 17.64. The lowest was 4.08. And the median was 7.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ReproCELLorp Cyclically Adjusted Revenue per Share Related Terms


ReproCELLorp Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for ReproCELLorp's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReproCELLorp Cyclically Adjusted Revenue per Share Chart

ReproCELLorp Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.14 0.10 0.12 0.11

ReproCELLorp Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.12 0.12 0.10 0.11

FRA:6RC vs VRTX, REGN, ALNY: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, ReproCELLorp's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReproCELLorp Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReproCELLorp's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ReproCELLorp's Cyclically Adjusted PS Ratio falls into.


FRA:6RC
57GF Score
ReproCELL Incorp FRA:6RC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ReproCELLorp Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ReproCELLorp's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.036/112.7000*112.7000
=0.036

Current CPI (Mar. 2026) = 112.7000.

ReproCELLorp Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.039 98.100 0.045
201609 0.038 98.000 0.044
201612 0.048 98.400 0.055
201703 0.054 98.100 0.062
201706 0.027 98.500 0.031
201709 0.028 98.800 0.032
201712 0.028 99.400 0.032
201803 0.029 99.200 0.033
201806 0.031 99.200 0.035
201809 0.031 99.900 0.035
201812 0.029 99.700 0.033
201903 0.032 99.700 0.036
201906 0.030 99.800 0.034
201909 0.037 100.100 0.042
201912 0.038 100.500 0.043
202003 0.036 100.300 0.040
202006 0.019 99.900 0.021
202009 0.050 99.900 0.056
202012 0.037 99.300 0.042
202103 0.036 99.900 0.041
202106 0.040 99.500 0.045
202109 0.063 100.100 0.071
202112 0.048 100.100 0.054
202203 0.069 101.100 0.077
202206 0.057 101.800 0.063
202209 0.076 103.100 0.083
202212 0.053 104.100 0.057
202303 0.060 104.400 0.065
202306 0.043 105.200 0.046
202309 0.044 106.200 0.047
202312 0.047 106.800 0.050
202403 0.045 107.200 0.047
202406 0.041 108.200 0.043
202409 0.048 108.900 0.050
202412 0.051 110.700 0.052
202503 0.061 111.100 0.062
202506 0.030 111.700 0.030
202509 0.030 112.000 0.030
202512 0.037 113.000 0.037
202603 0.036 112.700 0.036

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.11 mean?
ReproCELLorp (FRA:6RC) has a Cyclically Adjusted Revenue per Share of €0.11 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ReproCELLorp and its competitors.
Is ReproCELLorp's Cyclically Adjusted Revenue per Share too high?
ReproCELLorp's current Cyclically Adjusted Revenue per Share is €0.11. Overall, ReproCELLorp has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does ReproCELLorp's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
ReproCELLorp's Cyclically Adjusted Revenue per Share of €0.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ReproCELLorp and its competitors. ReproCELLorp's current Cyclically Adjusted Revenue per Share is €0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ReproCELLorp stock overvalued right now?
ReproCELLorp (FRA:6RC) has a current Cyclically Adjusted Revenue per Share of €0.11. The stock's GF Value™ is €0.59, compared to a current price of €0.47 — trading 19.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.11. ReproCELLorp's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For ReproCELLorp (FRA:6RC), the current Cyclically Adjusted Revenue per Share is €0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ReproCELLorp (FRA:6RC) Overvalued in 2026?

Based on GuruFocus' analysis, ReproCELLorp stock appears to be undervalued. The current stock price of €0.47 is trading 19.7% below its estimated GF Value™ of €0.59.

Key valuation signals for FRA:6RC:

  • Cyclically Adjusted Revenue per Share: €0.11
  • GF Value™: €0.59 vs. price of €0.47 (19.7% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the FRA:6RC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ReproCELLorp Business Description

Other Exchanges 4978:Japan
Address KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.
57GF Score

Get the complete analysis for FRA:6RC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.47
Price
€0.59
GF Value